Q44-13282-05013
3 vaccinations
5 coded responses
23 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 986 / WA
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Registered in v-safe
-
2021-03-27
Dose 1 — Pfizer-BioNTech
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
-
2021-04-10
Survey response — day 14, dose 1MedDRA: Blepharospasm — Feeling: GoodFree text: Eye twitchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-17
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-24
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-26
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: Good · Muscle or body achesFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Survey response — day 7, dose 2MedDRA: Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Fatigue or tirednessFree text: Congestion and sore throat from common coldMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-07-20
-
2021-10-19
Survey response — 6 months, dose 2MedDRA: Gastrooesophageal reflux disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: GERDMedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-21
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-12-01
Dose 3 — Pfizer-BioNTech
-
2022-04-20
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-20
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-22
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-06-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — day 14, dose 1
Symptoms: Eye twitch
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Congestion
Release 8 — day 7, dose 2
Systemic reaction (other): Congestion and sore throat from common cold
Release 10 — 6 months, dose 2
Symptoms: GERD
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blepharospasm | ✓ | ✓ | ✓ |
| SD | Gastrooesophageal reflux disease | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Nasopharyngitis | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release